Found: 13
Select item for more details and to access through your institution.
Atenolol and mortality events in patients with chronic kidney disease: Analysis of data from the Japanese Adverse Drug Event Report database.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2022, v. 130, n. 4, p. 553, doi. 10.1111/bcpt.13717
- By:
- Publication type:
- Article
Olanzapine‐associated dose‐dependent alterations for weight and metabolic parameters in a prospective cohort.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2022, v. 130, n. 4, p. 531, doi. 10.1111/bcpt.13715
- By:
- Publication type:
- Article
Sacubitril/valsartan, sodium‐glucose cotransporter 2 inhibitors and vericiguat for congestive heart failure therapy.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2022, v. 130, n. 4, p. 425, doi. 10.1111/bcpt.13714
- By:
- Publication type:
- Article
Effects of Zuojin Pill (Rhizoma Coptidis and Fructus Evodiae preparation) on the pharmacokinetics and side effects of venlafaxine in humans.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2022, v. 130, n. 4, p. 522, doi. 10.1111/bcpt.13713
- By:
- Publication type:
- Article
The association of four genetic variants with myelosuppression in gemcitabine‐treated Japanese is not evident in gemcitabine/carboplatin‐treated Swedes.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2022, v. 130, n. 4, p. 513, doi. 10.1111/bcpt.13712
- By:
- Publication type:
- Article
Use of chlorprothixene and the risk of diabetes and major adverse cardiovascular events: A nationwide cohort study.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2022, v. 130, n. 4, p. 501, doi. 10.1111/bcpt.13711
- By:
- Publication type:
- Article
A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD).
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2022, v. 130, n. 4, p. 439, doi. 10.1111/bcpt.13710
- By:
- Publication type:
- Article
Diclofenac in vitro microdialysis study comparing different experimental set‐ups to improve quantitative recovery.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2022, v. 130, n. 4, p. 468, doi. 10.1111/bcpt.13709
- By:
- Publication type:
- Article
SmartPAN: In vitro and in vivo proof‐of‐safety assessments for an intra‐operative predictive indicator of postoperative pancreatic fistula.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2022, v. 130, n. 4, p. 542, doi. 10.1111/bcpt.13708
- By:
- Publication type:
- Article
Plasma concentrations of methylphenidate enantiomers in adults with ADHD and substance use disorder, with focus on high doses and relationship to carboxylesterase activity.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2022, v. 130, n. 4, p. 492, doi. 10.1111/bcpt.13707
- By:
- Publication type:
- Article
Describing long‐term opioid use utilizing Nordic prescription registers—A Norwegian example.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2022, v. 130, n. 4, p. 481, doi. 10.1111/bcpt.13706
- By:
- Publication type:
- Article
Pro‐inflammatory cytokines/chemokines, TNF‐α, IL‐6 and MCP‐1, as biomarkers for the nephro‐ and pneumoprotective effect of silibinin after hepatic ischemia/reperfusion: Confirmation by immunohistochemistry and qRT‐PCR
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2022, v. 130, n. 4, p. 457, doi. 10.1111/bcpt.13704
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2022, v. 130, n. 4, p. 423, doi. 10.1111/bcpt.13604
- Publication type:
- Article